Tissera, Inc. Reports Achievement of Proof of Concept of the Curative Effect of Its Transplantation Technology in Large Animal Diabetic Model

HERZLIYA, Israel--(BUSINESS WIRE)--Tissera, Inc. (OTCBB:TSSR) reports the achievement of a significant milestone in its ongoing large animal diabetic model experiments of pancreatic xenotransplantation, designed for the future treatment of insulin-dependent (type I) diabetes mellitus.